CSL to acquire majority stake in
Chinese plasma fractionator ASX Announcement

13-June-2017 — The transaction will better serve patients with rare and serious diseases in this important high growth market... More.

Applications Open for CSL Centenary Fellowship Program
Applications Open for CSL Centenary Fellowship Program

01-June-2017 — $1.25 Million Funding Available to Australia’s Best and Brightest Biomedical Researchers. More.


Other recent news:

10-July-2017 — CSL Limited has become aware that Bioverativ has filed complaints in the U.S. District Court for the District of Delaware and with the International Trade Commission. More.
23-June-2017 — CSL announced that the FDA has approved CSL Behring’s HAEGARDA®. More.
12-April-2017 — CSL remains highly confident that CSL830 does not infringe any valid claim of the Shire ViroPharma patent and will vigorously defend against the claims. More.

© 2017 CSL Limited